FindTrial
Sign In

The Efficacy of ChulaCancer LINE Chat Proactive and Interactive Program for Giving Supportive Management of Chemotherapy Adverse Drug Events Compare with Usual Care in Cancer Patients Receiving Chemotherapy, a Pilot Study and Randomized Controlled Trial

The Efficacy of ChulaCancer LINE Chat Proactive and Interactive Program for Giving Supportive Management of Chemotherapy Adverse Drug Events Compare with Usual Care in Cancer Patients Receiving Chemotherapy, a Pilot Study and Randomized Controlled Trial

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240903001
Enrollment
60
Registered
2024-09-03
Start date
2024-10-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Self care after receiving chemotherapy in patient with early-stage colorectal cancer or early-stage breast cancer Early-stage colorectal cancer Early-stage breast cancer LINE application Chatbot CAPEOX AC regimen TC regimen Quality of life Treatment related adverse events

Interventions

Chatbot in LINE application for communication of management of chemotherapy-related adverse events,Usual care
Experimental Device,No Intervention No treatment
Group 1,Group 2

Sponsors

King Chulalongkorn Memorial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Age more than 18 uears old 2.Eastern Cooperative Oncology Group (ECOG) performance status equal to 0 to 2 3.Plan to receiving adjuvant chemotherapy

Exclusion criteria

Exclusion criteria: Can't use smart phone

Design outcomes

Primary

MeasureTime frame
Number of healthcare utilization 12 wk after beginning of intervention Chi-square—

Secondary

MeasureTime frame
Change in EORTC QLQ-C30 score 12 wk after beginning of intervention Chi-square—

Countries

Thailand

Contacts

Public ContactNarawitch Sompornpailin

King Chulalongkorn Memorial Hospital

na2672000@gmail.com0914365686

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026